Spring Sale Limited Time 65% Discount Offer - Ends in 0d 00h 00m 00s - Coupon code: pass65
marks4sure logo
Under which of the following circumstances would a regulatory authority require a more detailed premarket submission, a more rigorous audit, and/or the provision of more performance evaluation data than would normally apply to an IVD device of that risk class?
According to the GHTF IVD guidance, which of the following is the CORRECT classification for a blood glucose self-testing kit?
During a regulatory authority inspection of a manufacturing site, the inspector observes that one of the medicinal products manufactured at the site is not GMP compliant. The product Is distributed globally.
Which of the following is the most appropriate action to take FIRST?
After numerous failed attempts to decrease an identified risk in a medical device to an acceptable level, the medical device continues to have unacceptable risks. However, the development team wants to continue development. Which is the BEST recommendation to make in this situation?
During the review of a design dossier, the reviewer asks why the company has only carried out a top-down risk approach. The reviewer is referring to which of the following?
In a distribution contract for high-risk medical devices, which of the following regulatory requirements is the MOST important for the distributor?
A drug product presents degradation during the manufacturing process. In addition to the amount, what information should be provided FIRST in order to use API overage?
A company is developing a new product for the global market. A new international guideline will recommend relevant studies in the pediatric population, and the guideline will be effective before the approval of the company ' s new product.
What is the BEST advice the regulatory affairs professional can provide to minimize the impact of this guideline on the successful registration of the new product?
Which of the following BEST describes the content of the " Physical, Chemical, and Pharmaceutical Properties and Formulation " section of an IB?
As a member of the product launch review committee, a regulatory affairs professional discovers a major issue with the labeling of a product prior to production. In addition to informing the committee, which is the BEST approach to address the issue?
SOPs for preventive and corrective actions MUST include the procedure to eliminate which of the following?
Company X has a patent for an anti-inflammatory drug that will expire in one year. In order to minimize the effect of the patent expiration, which is the BEST action for the company to take?
At a recent scientific meeting, Company Y had two booths:
• At one booth, Company Y provided brochures on a completed Phase II study.
• In an adjacent booth, Company Y ' s sales professionals were promoting one of Company Y ' s marketed products.
A regulatory affairs-professional at Company X sends a letter to a counterpart at Company Y requesting that Company Y stop this practice in the future and demanding a formal response to the letter. How should the regulatory affairs professional at Company Y BEST respond?
A company is developing a line of products for which no ISO standard of performance is available. As a result, the company wishes to propose developing such a standard. Whom should the company contact in order to start the development of the new standard?
A regulatory authority announces an inspection of a regulatory affairs professional ' s facility during a holiday season when most of the staff Is not available. What is the MOST practical approach to this dilemma?
As part of the regulatory strategy for companies intending to manufacture a psychotropic product, which of the following approvals should be received FIRST?
The manufacturer of an API was changed from Company X to Company Y during the late stage of a new drug development. Despite differences in the manufacturing processes of the companies, both APIs meet the current specifications. Which is the MOST appropriate information to include in the final submission documents?
Who has the PRIMARY responsibility for recall of products with quality defects?
According to ICH, how many stability time points are normally required to establish a two-year shelf life for a product?
A materials supplier informs a company that it intends to stop supplying a material critical to the manufacture of the company ' s products. What action should the company take FIRST?
A company is developing a new medical device. During which initial stage is it MOST appropriate (or a regulatory affairs professional to become involved?
Which of the following is NOT considered a serious adverse event in a cardiovascular clinical trial?
An inspection of a manufacturing site determines that a number of manufacturing changes have been implemented without obtaining the necessary regulatory clearance. Which of the following actions should the regulatory affairs professional complete FIRST?
Which of the following is the MOST desirable timing and approach for a regulatory affairs professional who wants to provide feedback on proposed new regulations?
Which of the following is MOST appropriate for the purpose of lot release of biologics?
In preparation for the development of a new line of products, a regulatory affairs professional is asked to prepare a short presentation for senior management. Which of the following topics is MOST important to cover?
TESTED 02 May 2026